Japan now first to use oral Lonsurf (Tas-102)for mCRC that has seen standard treatment failures,

coloCan

made by Taiho and soon to be tested worldwide

http://www.taiho.co.jp/english/news/20140324.html

 

and further down the road

http://blogs.jeffersonhospital.org/atjeff/2014/03/24/combining-radiation-therapy-colon-cancer-vaccines/

www.newswise.com/articles/view/615426/?sc=dwhn

 

 

 

 

coloCan

China is now studying fruquintinib (HMPL-013),

while the Netherlands is using a combo approach to inhibit both MEK and EGFR/ERBB2

and this may be of interest to someone

http://medicalxpress.com/print315209985.html

 

latest on CRC/aspririn

http://medicalxpress.com/print315487111.html

 

 

 

 

tanstaafl

perspective

Thanks, Steve. "Yes" to the 1/4 aspirin.  Taiho's new drug I had a "hmmmm, so so" reaction to their early results, side efffects for small gains.  Note, I am still most impressed with Taiho's UFT, commercialized in the 1980's as the nicest 5FU chemo, when used skillfully.

The antibody drugs, to me are better lab creatures for all but the highest overexpressions.  I am interested in their initial lab result for inhibition to guide treatment with natural inhibitors, but would rather have corresponding test markers guiding natural inhibitors use.